Home / Stocks / HKMPF

HKMPF (Pharmaceuticals) Stock Valuation & Fair Value Fairly valued

HKMPF (Pharmaceuticals) trades at a blended P/E of 9.6, about 44% below its historical normal valuation, with a forward growth estimate of 7.2% and a PEG of 1.33. Analysts' one-year estimates have been hit 36% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

Blended P/E
9.6
Normal P/E
17.3
PEG
1.33
Fwd growth
7.2%
Div yield
4.0%
RSI (14)
16.1
Oversold

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-09-19.

Blended P/E and rating by weekBlended P/E moved from 9.6 to 9.6 between 2026-09-19 and 2026-09-21, against a normal P/E of 17.3, with 0 rating changes over 2 recorded weeks.2026-09-19: P/E 9.6, Fairly valued (recalculated)2026-09-21: P/E 9.6, Fairly valued10.012.014.016.0Sep 19Sep 20Sep 21Normal P/E 17.3
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.

WeekBlended P/EPremium to normal P/ERating
2026-09-19P/E 9.6-44%Fairly valued
2026-09-21P/E 9.6-44%Fairly valued ← now

Frequently asked questions

Is HKMPF overvalued?

At a blended P/E of 9.6 versus its historical normal P/E of 17.3, HKMPF trades about 44% below its typical valuation, with a PEG of 1.33 on 7.2% forward growth. tickerseer currently rates it fairly valued.

What is HKMPF's fair value and PEG?

HKMPF trades at a blended P/E of 9.6 against a historical normal P/E of 17.3, a PEG of 1.33, and a forward growth estimate of 7.2%.

Has tickerseer's rating of HKMPF changed?

tickerseer's rating has been fairly valued since 2026-09-19.

Industry: Pharmaceuticals. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.